Medical device groups float – then sink
Medtechs rushed for the markets last year, but had an uneasy time once there.
Go or no go? Sanofi’s Cablivi leads February’s approvals charge
Others in the FDA queue include Bausch’s psoriasis therapy Duobrii and Motif Bio’s antibiotic Iclaprim.
